Protein Terminal Analysis

Protein N-Terminal Sequencing Service — Edman Degradation & LC-MS/MS

Determine the N-terminal sequence of your protein by Edman degradation and LC-MS/MS. Confirm N-terminal boundaries, identify blocked or modified N-termini, and verify recombinant protein integrity with two complementary methods.

Edman Degradation LC-MS/MS Blocked N-Termini N-Terminal PTMs

Service Scope

Two complementary methods for N-terminal sequence determination

vertical_align_top

Edman

Chemical sequential degradation for unblocked N-termini.

LC-MS/MS

MS-based identification of blocked or modified N-termini.

Coverage

Up to 100% peptide coverage by multi-protease MS.

Sensitivity

As low as 1–10 µg protein required.

Amino acids resolvable by Edman.

100%

MS peptide coverage achievable.

Dual

Edman + MS methods available.

Service Details

Workflow

Platform

Applications

Deliverables

Case Study

Request a Quote

What Is Protein N-Terminal Sequencing?

Protein N-terminal sequencing remains the method of choice for validating the N-terminal boundaries of recombinant proteins, identifying the N-terminal end of protease resistance structural domains, and identifying proteins isolated from species whose majority of genomes have not been sequenced. N-terminal sequence confirmation is also a characterization requirement outlined in ICH Q6B for biopharmaceutical products.

Compared with the Edman degradation method, in MS-based protein N-terminal sequencing, the N-terminal amino acids don't need to be repeatedly cleaved, and the proteins are directly pretreated by digestive enzymes into small fragments to analyze by mass spectrometry. Different peptides can generate fragment ions with different m/z and different spectra to obtain more N-terminal sequence information due to the different masses of most amino acid residues. In addition, mass spectrometry N-terminal sequencing is not affected by the N-terminal end of the protein, and which can also sequence N-terminal blocked and chemically modified amino acids.

Creative Proteomics provides both Edman degradation and LC-MS/MS-based N-terminal sequencing, with the MS approach capable of achieving 100% coverage of the measured target protein sequence — including proteins with blocked or modified N-termini that are inaccessible to chemical methods. For complex samples where the N-terminal peptide may be present at low abundance, N-terminal enrichment strategies (TMPP/dimethyl labeling) can be applied to selectively isolate terminal peptides before MS analysis.

Scientific illustration showing N-terminal sequencing — Edman degradation chemical cycle on the left and LC-MS/MS fragmentation spectrum with b/y ion series on the right.

N-Terminal Sequencing Methods

Method	Principle	Read Length	Blocked N-Termini	Best Use Case
Edman Degradation	Sequential chemical removal and identification of N-terminal residues via phenylthiohydantoin (PTH) derivatives	Up to 70 residues	Not accessible	Confirming unblocked N-termini of purified proteins and synthetic peptides
LC-MS/MS (Primary)	Enzymatic digestion → N-terminal peptide isolation → CID/HCD fragmentation → b/y ion assignment	Single-residue confirmation + full sequence coverage	Accessible	N-terminally blocked or modified proteins; simultaneous N- and C-terminal detection

Our N-Terminal Sequencing Services

Two complementary methods — Edman degradation and LC-MS/MS — for complete N-terminal sequence determination, covering both unblocked and modified protein termini.

biotech

LC-MS/MS N-Terminal Sequencing

Mass spectrometry-based N-terminal sequencing identifies the N-terminal peptide by enzymatic digestion and tandem MS fragmentation. Not affected by N-terminal blocking, PEGylation, glycosylation, or other modifications. Simultaneous determination of N-terminal and C-terminal sequences in one experiment.

Orbitrap MS Multi-Protease

science

Edman Degradation Sequencing

The classical chemical method for sequential N-terminal residue identification. Remains the gold standard for confirming the identity of synthesized or purified peptides with unblocked N-termini. Capable of resolving up to 70 amino acid residues from the N-terminal end.

Chemical Method

edit_note

N-Terminal Modification Analysis

Identify and characterize N-terminal post-translational modifications — acetylation, methylation, formylation, pyroglutamate formation, and cyclization — that affect protein function, stability, and localization.

PTM Focus

lock_open

N-Terminal Blocking Resolution

When Edman degradation fails due to a blocked N-terminus (acetylated, pyroglutamylated, or formylated), LC-MS/MS-based sequencing is the solution. We specialize in identifying blocked N-terminal residues that chemical methods cannot access.

Blocked Termini

How N-Terminal Sequencing Works

A customized workflow for N-terminal peptide identification by mass spectrometry, designed to maximize sequence coverage and handle blocked or modified termini.

Sequence Analysis

Amino acid sequence of the target protein is analyzed computationally to select optimal proteases — trypsin, Glu-C, Lys-C, chymotrypsin, Asp-N, or Lys-N — for maximum N-terminal peptide coverage.

Protein Digestion

Selected proteases digest the target protein into peptides with overlapping coverage. Multi-enzyme strategies ensure the N-terminal region is represented by at least one identifiable peptide.

LC-MS/MS Acquisition

Peptides are separated by UPLC and analyzed by high-resolution tandem mass spectrometry using data-dependent acquisition. The N-terminal peptide is identified by its characteristic fragmentation pattern.

Database Search & Assembly

MS/MS spectra are searched against the protein sequence database. Confirmed peptides from each digest are aligned on the theoretical sequence. N-terminal peptide identity is verified by b/y ion series.

Reporting & Delivery

A final report includes the N-terminal sequence, sequence coverage map, annotated MS/MS spectra supporting terminal identification, and a summary of any modifications detected at the N-terminus.

Technology Platform for N-Terminal Sequencing

Close-up of UHPLC and Orbitrap mass spectrometer instrumentation used for high-resolution protein N-terminal sequencing analysis.

biotech

Orbitrap / Q-Exactive LC-MS/MS

High-resolution mass spectrometry with ≤3 ppm mass accuracy. HCD and ETD fragmentation modes generate complementary ion series for confident N-terminal peptide identification.

science

Edman Degradation Sequencer

Automated Edman degradation with PTH-amino acid detection for unblocked N-termini. Provides residue-by-residue confirmation for purified proteins and synthetic peptides.

filter_alt

N-Terminal Enrichment Strategies

TMPP (trimethoxyphenyl phosphonium) and dimethyl labeling for selective N-terminal peptide enrichment. Negative selection workflows isolate native N-terminal peptides — including those with endogenous modifications — improving detection sensitivity in complex samples.

lock_open

Blocked N-Terminus Compatibility

Unlike Edman degradation, MS-based N-terminal sequencing works with acetylated, pyroglutamylated, formylated, PEGylated, and glycosylated N-termini — no deblocking chemistry required.

Advantages of Creative Proteomics N-Terminal Sequencing

Creative Proteomics provides N-terminal sequencing with two complementary methods — Edman degradation and LC-MS/MS — ensuring that both unblocked and modified N-termini can be analyzed.

percent

100% Sequence Coverage

Multi-protease MS strategies achieve complete peptide coverage of the target protein, with up to 70 N-terminal residues confirmable by Edman degradation.

lock_open

Unblocked & Blocked N-Termini

MS-based sequencing is not affected by N-terminal modifications — acetylation, pyroglutamate, formylation, PEGylation, and glycosylation are all compatible.

auto_awesome

Automatic Sequence Analysis

Computational peptide-spectrum matching with expert manual review provides more accurate sequence assignment than chemical interpretation alone.

schema

Low Sample Requirement

Only 1–10 µg of protein is required for MS-based N-terminal sequencing — significantly less than traditional chemical methods.

sync

N- and C-Terminal Simultaneously

The same LC-MS/MS experiment identifies both N-terminal and C-terminal peptides, providing complete terminal characterization in a single analysis.

description

Dual-Method Validation

Edman degradation and LC-MS/MS can be used orthogonally — Edman confirms unblocked residues while MS handles blocked or modified termini — for the most complete N-terminal characterization.

Applications of N-Terminal Sequencing

N-terminal sequencing supports protein characterization, biopharmaceutical QC, and research across multiple application areas.

fingerprint

Protein Identity & Sequence Confirmation

Verify the N-terminal sequence of recombinant proteins, confirm expression fidelity, and distinguish between protein isoforms and variants.

verified

Biopharmaceutical QC & Lot Release

Ensure batch-to-batch N-terminal consistency for protein therapeutics. Confirm N-terminal integrity as part of identity testing for regulatory submissions.

edit_note

N-Terminal PTM Characterization

Identify acetylation, methylation, formylation, pyroglutamate formation, and cyclization at the N-terminus — modifications that affect protein stability and function.

biotech

Protein Engineering & Design

Confirm successful introduction or deletion of N-terminal residues by site-directed mutagenesis. Validate engineered protein variants for structural and functional studies.

monitoring

Biomarker Discovery & Diagnostics

Identify novel protein biomarkers with disease-associated N-terminal sequences. Support development of diagnostic and prognostic assays targeting terminal epitopes.

psychology

Structural Biology & Folding Studies

Elucidate the role of the N-terminus in protein folding, stability, and assembly. Correlate N-terminal sequence features with three-dimensional structure.

Sample Requirements for N-Terminal Sequencing

Sample requirements vary depending on the method selected. The table below provides general guidance — final requirements should be confirmed during project evaluation.

Sample Type	Minimum Amount	Purity	Buffer Compatibility	Notes
Purified Proteins (Edman)	≥10–50 µg	≥95%	Volatile buffers; avoid detergents and high salt	N-terminus must be unblocked for Edman
Purified Proteins (LC-MS/MS)	≥5–10 µg	≥90% recommended	Water or volatile solvents preferred	Works with blocked or modified N-termini
Synthetic Peptides	≥1–5 µg	≥95%	Water, 0.1% formic acid	Specify expected N-terminal modifications
Gel Bands / Spots	Visible Coomassie band	Single band preferred	N/A	Excise with clean tools; ship in Eppendorf tube

What You Receive

Comprehensive N-terminal sequencing deliverables with raw data, processed results, and expert interpretation.

analytics

Annotated MS/MS Spectra

Annotated fragmentation spectra of the N-terminal peptide with b/y ion series labeled, supporting terminal residue assignment.

table_chart

Sequence Coverage Map

Color-coded map showing every confirmed residue with peptides from each protease overlaid on the theoretical sequence.

description

Executive Summary

Methods description, N-terminal sequence result, coverage information, modification summary, and expert interpretation notes.

folder_open

Raw Data Files

All raw MS data files and processed search results for independent verification of the reported N-terminal sequence.

For complementary protein characterization services — including C-terminal sequencing (determined simultaneously from the same LC-MS/MS experiment), peptide mapping for full-sequence confirmation, and peptide testing for synthetic peptide QC — contact our team to discuss your project requirements.

Open analytical report booklet showing N-terminal sequencing results — annotated MS/MS spectrum with b/y ions and sequence coverage map confirming the N-terminal peptide.

Published Research

MeCP2\_E1 N-Terminal Modifications Affect Protein Degradation Rate in Living Cells

Journal

Hum Mol Genet

Year

2017

DOI

10.1093/hmg/ddx300

Study Overview

Sheikh et al. (Human Molecular Genetics, 2017) investigated how N-terminal modifications of the MeCP2\_E1 protein isoform affect its degradation rate and stability in living cells. MeCP2 is a critical transcriptional regulator, and mutations in this protein cause Rett syndrome — a severe neurodevelopmental disorder. The Ala2Val mutation at the N-terminus was of particular interest because of its clinical association with disease pathology.

Key Methods

N-terminal sequencing by LC-MS/MS — confirmed the N-terminal sequence and modification state of both wild-type and Ala2Val mutant MeCP2\_E1 proteins
GFP-Trap affinity purification followed by tryptic digestion for mass spectrometry analysis
Q-Exactive Hybrid Quadrupole-Orbitrap MS — high-resolution mass spectrometry for peptide identification
FRAP and cycloheximide chase assays — measured protein mobility and degradation kinetics in living HEK293T and neuroblastoma cells

Relevance to N-Terminal Sequencing

Demonstrates the use of MS-based N-terminal sequencing to confirm the N-terminal sequence and modification state of a clinically relevant protein variant.
Shows how N-terminal modifications directly impact protein degradation rates — confirming the N-terminal sequence is not merely academic but has functional consequences.
The LC-MS/MS workflow used in this study mirrors Creative Proteomics' N-terminal sequencing approach: protein purification → tryptic digestion → high-resolution MS → sequence confirmation.

Key Finding

The study demonstrated that the Ala2Val mutation at the MeCP2\_E1 N-terminus led to significantly slower protein recovery rates and higher degradation rates compared to wild-type MeCP2. N-terminal sequencing by mass spectrometry was essential for confirming the identity and modification state of the protein variants, enabling the authors to attribute functional differences specifically to N-terminal sequence changes. These findings provide mechanistic insight into how N-terminal mutations contribute to Rett syndrome pathology.

Publication Reference

Sheikh TI, de Paz AM, Becker K, Ausió J, Vincent JB. MeCP2\_E1 N-terminal modifications affect its degradation rate and are disrupted by the Ala2Val Rett mutation. Hum Mol Genet. 2017;26(21):4132–4141. DOI: 10.1093/hmg/ddx300.

Frequently Asked Questions

What is the difference between Edman degradation and LC-MS/MS for N-terminal sequencing?expand_more

Edman degradation sequentially removes and identifies N-terminal amino acids by chemical reaction — it is precise but requires an unblocked N-terminus and is limited to about 70 residues. LC-MS/MS identifies the N-terminal peptide by enzymatic digestion and tandem mass spectrometry fragmentation — it works with blocked, modified, or unblocked N-termini and can be combined with C-terminal sequencing in one experiment. Edman is the gold standard for unblocked purified proteins; LC-MS/MS is the method of choice for blocked or modified N-termini.

What does it mean if my N-terminus is "blocked"?expand_more

A "blocked" N-terminus means the terminal amino group is chemically modified — commonly by acetylation, pyroglutamate formation (from N-terminal Gln or Glu), or formylation. These modifications prevent Edman degradation from proceeding because the chemical reaction requires a free α-amino group. LC-MS/MS-based N-terminal sequencing is not affected by N-terminal blocking and can identify blocked residues directly without requiring deblocking chemistry.

How much protein is needed for N-terminal sequencing?expand_more

For LC-MS/MS-based N-terminal sequencing, 5–10 µg of purified protein is typically sufficient. For Edman degradation, 10–50 µg is recommended to ensure reliable residue calling across multiple cycles. Provide the highest available purity and avoid detergents, glycerol, or high-salt buffers that can interfere with both methods.

Can you sequence both N- and C-termini from the same sample?expand_more

Yes. Our LC-MS/MS-based approach identifies both the N-terminal and C-terminal peptides from the same enzymatic digest and LC-MS/MS run. This simultaneous terminal sequencing reduces sample consumption and provides a complete picture of protein terminal integrity in a single experiment.

What types of N-terminal modifications can you detect?expand_more

LC-MS/MS-based N-terminal sequencing detects mass-shifting modifications at the N-terminus, including acetylation (+42 Da), formylation (+28 Da), pyroglutamate formation (−17 Da from Gln, −18 Da from Glu), methylation (+14 Da), PEGylation (variable), and glycosylation (variable). Non-mass-shifting modifications like cyclization without mass change are identifiable by retention time shifts and specific fragmentation patterns.